For Your Patients: Navigating Treatment Options in Early Stage Alzheimer’s Disease — Medications are available to stabilize symptoms and even delay progression ...

The EU has approved Eisai and Biogen's Leqembi for a subset of patients with early-stage Alzheimer's disease, more than two years after it was filed.

Eisai and Biogen’s Alzheimer’s disease therapy Leqembi is due to be launched in Japan, its second market, on 20th December, and will be priced quite a lot lower there than in the US.

Time Course of Alzheimer's Disease Damage from the disease begins to accrue years or decades before any symptoms begin. A given individual presenting at age 70 might be expected to spend a decade ...

Keep track of the live scoring as the Springboks aim for a convincing win against Italy in their second Test of the year.

2025 FIFA Club World Cup schedule, scores Final Match 63: Chelsea vs PSG — Sunday, July 13, 3pm ET, MetLife Stadium, East Rutherford ...

Rhythm Pharma's Oral Drug For Rare Obesity Shows Promise Rhythm's bivamelagon cut BMI and hunger scores in Phase 2 trial for hypothalamic obesity, prompting plans to discuss Phase 3 with regulators.

Find the latest iShares U.S. Aerospace & Defense ETF (ITA) stock quote, history, news and other vital information to help you with your stock trading and investing.